Vésale Bioscience rebrands as Inteliphage

Vésale Bioscience has become Inteliphage after five years, saying it is no longer just a research-driven biotech but is focused on bringing next-generation bacteriophage therapies into routine clinical care. The company says it is partnering with hospitals, researchers and industry to move phage-based therapies from bench to bedside worldwide.